New Zealand markets closed

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.730.00 (0.00%)
At close: 04:00PM EDT
14.73 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
-
-
-
-
0
Selling general and administrative
2,176
2,176
2,174
2,616
5,012
Total operating expenses
2,176
2,176
2,174
2,616
5,012
Operating income or loss
-2,176
-2,176
-2,174
-2,616
-5,012
Interest expense
-
-
-
-
0
Total other income/expenses net
139
139
445
144
1,948
Income before tax
-1,169
-1,169
-1,541
-2,452
-3,014
Income tax expense
12
12
3
3
14
Income from continuing operations
-1,181
-1,181
-1,544
-2,455
-3,028
Net income
-1,181
-1,181
-1,544
-2,455
-3,028
Net income available to common shareholders
-1,181
-1,181
-1,544
-2,455
-3,028
Basic EPS
-0.10
-0.08
-0.11
-0.18
-0.23
Diluted EPS
-0.10
-0.08
-0.11
-0.18
-0.23
Basic average shares
14,183
14,299
13,524
13,407
13,380
Diluted average shares
14,183
14,299
13,524
13,407
13,380